サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1363224

ケモインフォマティクスの市場規模、シェア、動向分析レポート：用途別、地域別、セグメント予測、2023年～2030年

Chemoinformatics Market Size, Share & Trends Analysis Report By Application (Chemical Analysis, Drug Discovery, Drug Validation, Others), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 105 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ケモインフォマティクスの市場規模、シェア、動向分析レポート：用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年09月25日
発行: Grand View Research
ページ情報: 英文 105 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ケモインフォマティクス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のケモインフォマティクス市場規模は2030年までに94億1,000万米ドルに達し、予測期間中に15.5%のCAGRを記録すると予測されています。

市場開拓に影響を与える主な決定要因には、最新の医薬品開発プロセスの絶え間ない改善、研究におけるインシリコ技術の利用の増加、医薬品開発プロセスにおける研究開発費全体の削減など、ケモインフォマティクスアプローチの採用に関連する利点などがあります。

ケモインフォマティクスは、様々な段階での医薬品設計に数多く応用されているため、医薬品開発市場の成長はケモインフォマティクスの需要を押し上げると思われます。ターゲットの特定から潜在的な医薬品候補としての開発まで、ケモインフォマティクス・ツールは重要な役割を果たしています。

ハイ・スループット・スクリーニング（HTS）プロセスによるヒット化合物の生成、ターゲット化合物の選択、仮想構造の生成、化合物の薬物動態学的特性および毒性の予測、定量的構造関係の決定において、様々なイン・シリコ・ツールが大きく貢献していることが、ケモインフォマティクス市場の成長の大きな原動力となっています。

創薬プロセスに投資される長いスパンとともに発生する重いコストは、研究活動においてケモインフォマティクス技術の統合を不可欠なものにしています。ケモインフォマティクスは、科学者や化学研究者が、創薬やその他の関連する調査研究に関連する、より適切な意思決定を行う上で役立っています。さらに、効率的で効果的な医薬品に対する需要の増加、研究開発への投資の増加、老人人口の増加、生活習慣病患者の急増は、市場の成長を積極的に促進すると予想されます。ケモインフォマティクスのツールやソフトウエアの主な用途は、薬剤設計と創薬であり、最大の用途です。

ケモインフォマティクスは、化学医薬品の開発と研究の分野に著しい貢献をしています。この分野の成長は、スクリーニング作業や調査研究において継続的に生成される生データが原動力となっています。ケモインフォマティクスのインシリコツールは、効果的なデータ管理を支援し、データの検索と解析を容易にすることで、医薬品開発プロセスやその他の研究に関連する研究に携わる科学者に、アクセス可能な情報の大規模データベースを提供します。

ケモインフォマティクスの分野では、3次元化学構造データベースの開発が、調査方法を大きく助けた。コンピュータ支援合成設計、コンピュータ支援構造解明、ケモメトリックスにおけるケモインフォマティクス・プラットフォームの応用は、市場の成長にさらに貢献しています。

計算技術の進歩は、市場成長の大きな促進要因となっています。この方向では、計算、3D構造生成、分子グラフィックス、複雑なデータ表示のためのスーパーコンピュータやシリコングラフィックスコンピュータの市場開拓が、ケモインフォマティクス市場の成長を推進する上で極めて重要です。先進的なWEB技術の登場と、それらがインシリコ計算技術に組み込まれたことで、この分野は完全に革命的な変化を遂げました。

より良い結果を得るための高度で効率的な技術に対するニーズの高まりにより、ケモインフォマティクス分野は製薬業界にとって不可欠なものとなっています。治療効果の高い医薬品に対するニーズの高まりと、研究開発分野への投資の増加、コンピュータ技術の進歩が相まって、近い将来に市場が成長・繁栄するための有利な機会がもたらされています。

ケモインフォマティクス市場レポートハイライト

  • 創薬セグメントは予測期間中に有利なCAGRを記録すると予測されます。同分野の高成長に寄与する主な要因としては、研究開発への投資の増加、薬剤分子としての潜在的リードの成功率が比較的低いことなどが挙げられます。
  • 2022年には、北米がケモインフォマティクス市場を43.6%以上の収益シェアで支配しました。その要因としては、研究開発イニシアチブに関連する高額の投資、技術の進歩、医薬品製造業界における主要プレイヤーの存在、生活習慣病の有病率の増加などが挙げられます。世界の研究開発費に関しては、北米が最大のシェアを占めています。また、ADME毒性学市場でも大きなシェアを占めており、ケモインフォマティクス市場の成長をさらに促進しています。
  • アジア太平洋は最も急速に成長している地域市場の1つであり、予測期間中にCAGR 20.3%で成長します。この市場の成長は、インド、中国、シンガポールなどの経済圏で行われている研究活動の拡大に起因しています。これらの国々で研究活動を行う主な利点としては、製造コストや労働コストが低いこと、規制がそれほど厳しくないことなどが挙げられ、多くの多国籍企業がアジア太平洋地域に進出しています。さらに、研究開発インフラを改善するために投入される政府の取り組みや資金が、市場の成長をさらに後押しします。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ケモインフォマティクス市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 業界のバリューチェーン分析
    • 償還の枠組み
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • ケモインフォマティクス市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 ケモインフォマティクス：用途別推定・動向分析

  • ケモインフォマティクス市場：重要なポイント
  • ケモインフォマティクス市場：動向と市場シェア分析、2022年と2030年
  • 化学分析
  • 創薬
  • 医薬品の検証
  • その他

第5章 ケモインフォマティクス市場：地域別推定・動向分析

  • 地域別の見通し
  • 地域別のケモインフォマティクス市場：マーケットプレースにおける重要なポイント
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第6章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • BIOVIA (formerly Accelrys)
    • ACD/Labs, Inc.
    • Agilent Technologies, Inc.
    • Cambridgesoft Corp.
    • ChemAxon, Inc.
    • Bio-Rad Laboratories, Inc.
    • Schrodinger, LLC
    • Molecular Discovery Ltd.
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 3 North America chemoinformatics market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 5 Canada chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 6 Europe chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 7 Europe chemoinformatics market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 9 UK chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 10 France chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 11 Italy chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 12 Spain chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 13 Sweden chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 14 Norway chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 15 Denmark chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific chemoinformatics market, by region, 2018 - 2030 (USD Million)
  • Table 18 China chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 19 Japan chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 20 India chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 21 Thailand chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 22 South Korea chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 23 Latin America chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 24 Latin America chemoinformatics market, by region, 2018 - 2030 (USD Million)
  • Table 25 Brazil chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 26 Mexico chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 27 Argentina chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 28 Middle East and Africa chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa chemoinformatics market, by region, 2018 - 2030 (USD Million)
  • Table 30 South Africa chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 31 Saudi Arabia chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 32 UAE chemoinformatics market, by application, 2018 - 2030 (USD Million)
  • Table 33 Kuwait chemoinformatics market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Chemoinformatics: Market outlook
  • Fig. 9 Chemoinformatics: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Chemoinformatics market driver impact
  • Fig. 15 Chemoinformatics market restraint impact
  • Fig. 16 Chemoinformatics market strategic initiatives analysis
  • Fig. 17 Chemoinformatics market: Application movement analysis
  • Fig. 18 Chemoinformatics market: Application outlook and key takeaways
  • Fig. 19 Chemical analysis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Drug validation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Global chemoinformatics market: Regional movement analysis
  • Fig. 24 Global chemoinformatics market: Regional outlook and key takeaways
  • Fig. 25 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: 978-1-68038-913-5

Chemoinformatics Market Growth & Trends:

The global chemoinformatics market size is expected to reach USD 9.41 billion by 2030, registering a CAGR of 15.5% during the forecast period, according to a new report by Grand View Research, Inc.. Some major determinants influencing the market growth include the constantly improving modern drug development processes, increasing use of in-silico techniques in research, and the advantages associated with employing the chemoinformatics approach, such as the reduction in the overall R&D expenditure during the drug development process.

The ever increasing growth of the drug development market will boost the demand for chemoinformatics owing to its numerous applications in drug designing at various stages. Right from target identification to its development as a potential drug candidate, chemoinformatics tools play a crucial part.

The significant contributions of the varying in silico tools in the generation of hits through the High Throughput Screening(HTS) process, target compound selection, virtual structure generation, Pharmacokinetic property and toxicity prediction of chemical compounds, and the quantitative-structure relationship determination have been a major driving force for the growth of the chemoinformatics market.

The heavy costs incurred along with the long time span invested in the drug discovery process has made the integration of the chemoinformatics techniques essential in the research activities. It aids the scientists and chemical researchers in making better decisions pertaining to drug discovery and other related research studies. Furthermore, the increasing demand for efficient and effective medicines, rising investments in R&D, growing geriatric population, and the burgeoning number of individuals with lifestyle related diseases are expected to positively reinforce the market growth. The key applications of the chemoinformatics tools and softwares in drug designing and discovery has been its largest application and is expected to grow further with further advances in the drug discovery process.

Chemoinformatics has made marked contributions to the areas of chemical drug development and research. The growth of this field is driven by the continually generated raw data in screening operations and research studies. Chemoinformatics in silico tools aid in effective data management, which facilitate data retrieval and analysis thus providing large databases of accessible information to scientists involved in both, the drug development process and other research related studies.

The development of three dimensional chemical structure databases has been a significant achievement in the field of chemoinformatics as it has significantly aided the research process. Applications of chemoinformatics platforms in computer-assisted synthesis designing, computer-assisted structure elucidation, and chemometrics have further contributed to the market growth.

The advancements in computational technology have been a high impact rendering driver for the market growth. In this direction, the development of super computers and silicon graphics computer for calculations, 3D structure generation, molecular graphics, and complex data display have been pivotal in propelling the growth of the chemoinformatics market. With the advent of advanced WEB technologies and their incorporation in the in-silico computational techniques have totally revolutionized this field.

The increasing needs for advanced and efficient technologies to yield better results has made the chemoinformatics area an indispensable part of the pharmaceutical industry. The surging need for therapeutically-effective medicines coupled with the increasing investments in the R&D area and the advancements in computer technologies provide lucrative opportunities to the market for it to grow and flourish in the near future.

Chemoinformatics Market Report Highlights:

  • The drug discovery segment is expected to witness a lucrative CAGR during the forecast period. The key factors contributing to the segment's high growth include the increasing investments in R&D and the relatively low success rate of the potential leads as drug molecules.
  • In 2022, North America dominated the chemoinformatics market with a revenue share of over 43.6% on account of the following factors: the high investments pertaining to the R&D initiatives, technological advancements, the presence of major players in the drug manufacturing industry, and the increasing prevalence of lifestyle-related diseases. With respect to the global R&D spending, North America holds the largest share. Also, it holds a major share in the ADME-toxicology market that further spurs the growth of the chemoinformatics market.
  • Asia Pacific is identified as one of the fastest growing regional markets, growing at a lucrative CAGR of 20.3% during the forecast period. The growth of this market can be attributed to the growing research activities being conducted in economies, such as India, China, and Singapore. The key advantages associated with undertaking research activities in these countries include the low manufacturing and labor costs and the less stringent regulations, which attract many multinational players to the Asia Pacific region. Additionally, the government initiatives and funds that are deployed to improve the R&D infrastructure will further drive the market growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Chemoinformatics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
    • 3.4.2. Market restraint analysis
  • 3.5. Chemoinformatics Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape

Chapter 4. Chemoinformatics : Application Estimates & Trend Analysis

  • 4.1. Chemoinformatics Market: Key Takeaways
  • 4.2. Chemoinformatics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Chemical Analysis
    • 4.3.1. Chemical analysis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Drug Discovery
    • 4.4.1. Drug discovery market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Drug Validation
    • 4.5.1. Drug validation market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Chemoinformatics Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Chemoinformatics Market by Region: Key Marketplace Takeaway
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. BIOVIA (formerly Accelrys)
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. ACD/Labs, Inc.
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Agilent Technologies, Inc.
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Cambridgesoft Corp.
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. ChemAxon, Inc.
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Bio-Rad Laboratories, Inc.
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Schrodinger, LLC
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Molecular Discovery Ltd.
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives